Market Access World USA 2012
October 16 - 18, 2012
Boston MA , USA
The most comprehensive pharma market access forum in the US
Experts in market access, pricing and health policy will provide delegates with the most comprehensive review of the US health reform.
This event will examine new strategies to control drug costs and reduce budget deficits whilst widening patient access. You will hear a balanced discussion between industry and public, private sector payers.
• Keynote Speakers
Michael Anderson,Ted Buckley,Anita Burrell,Teresa DeLuca,Lida Etemad,Marcus Farbstein,Steve Feldman and many more.
Come to Market Access World USA 2012 to learn
• the impact of reimbursement models on market access
• how will CER differ from the EU HTA experience
• HTA agency policy and practice globally
• how the US economy will impact state Medicaid programs
• the impact of changing incentive structures
• the importance of risk sharing, value based pricing and pay for performance
• how to generate data specifically for payers in comparative effectiveness research
• how to overcome the challengers in the emerging markets of Latin America & Asia
Who should attend
• Health Policy
• Market Access
• Pricing & Reimbursement
• Health Economics/Outcomes
• HTA/Comparative Effectiveness
• Evidence Based Medicine
• Pharmacoeconomics
• Chief Pharmacy Officers
• Chief Medical Officers
• Marketing
• Medical Affairs
• Government, Payer & Stakeholder relations
Experts in market access, pricing and health policy will provide delegates with the most comprehensive review of the US health reform.
This event will examine new strategies to control drug costs and reduce budget deficits whilst widening patient access. You will hear a balanced discussion between industry and public, private sector payers.
• Keynote Speakers
Michael Anderson,Ted Buckley,Anita Burrell,Teresa DeLuca,Lida Etemad,Marcus Farbstein,Steve Feldman and many more.
Come to Market Access World USA 2012 to learn
• the impact of reimbursement models on market access
• how will CER differ from the EU HTA experience
• HTA agency policy and practice globally
• how the US economy will impact state Medicaid programs
• the impact of changing incentive structures
• the importance of risk sharing, value based pricing and pay for performance
• how to generate data specifically for payers in comparative effectiveness research
• how to overcome the challengers in the emerging markets of Latin America & Asia
Who should attend
• Health Policy
• Market Access
• Pricing & Reimbursement
• Health Economics/Outcomes
• HTA/Comparative Effectiveness
• Evidence Based Medicine
• Pharmacoeconomics
• Chief Pharmacy Officers
• Chief Medical Officers
• Marketing
• Medical Affairs
• Government, Payer & Stakeholder relations
Venue
Location: Revere Hotel – Boston Common
Discover a destination that redefines luxury and puts its own spin on the Boston experience. Just a stone’s throw away from the Commons, our boutique hotel takes inspiration from the city’s rich..
+1 617 482 1800
Related events
Market Access World USA October 23 - 24, 2015
Market Access World USA October 23 - 24, 2014
Market Access World USA October 23 - 24, 2013
Market Access World USA October 16 - 18, 2012
Market Access World USA October 4 - 6, 2011
Market Access World USA October 6 - 8, 2010
